NCT04528927View on ClinicalTrials.gov

Evaluation of the Efficacy and Safety of Treatments for Patients Hospitalized for COVID-19 Infection Without Signs of Acute Respiratory Failure, in Tunisia

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

May 15, 2020

Primary Completion Date

July 15, 2020

Study Completion Date

July 15, 2020

Conditions
COVID 19Patients Hospitalized
Interventions
DRUG

HCQ

600 mg on the 1st day as a starting dose then 200 mg \* 2 /D for 9 days

DRUG

Azithromycin

500 mg (1st day) then 250 mg / D for 4 days

DRUG

Doxycycline

200 mg per day for 10 days

DIETARY_SUPPLEMENT

Zinc

220 mg per day for 10 days

Trial Locations (1)

1053

Eshmoun Clinical Research Centre, Tunis

Sponsors
All Listed Sponsors
collaborator

Eshmoun Clinical Research Center

NETWORK

collaborator

Datametrix

INDUSTRY

lead

Abderrahmane Mami Hospital

OTHER